Albanin A, Derived from the Root Bark of Morus alba L., Depresses Glutamate Release in the Rat Cerebrocortical Nerve Terminals via Ca2+/Calmodulin/Adenylate Cyclase 1 Suppression

다국어 초록 (Multilingual Abstract)

Decreasing synaptic release of glutamate may counteract glutamate excitotoxicity in many neurological diseases. In this study, we investigated the effect of albanin A, a constituent in the root bark of Morus alba L., on the release of glutamate in rat cerebral cortex nerve endings (synaptosomes). We found that albanin A at 5–30μM suppressed 4-aminopyridine (4-AP)-induced release of glutamate. This phenomenon was abolished by extracellular calcium removal or by vesicular transporter inhibition, and was associated with a decrease in intrasynaptosomal Ca2+ levels. However, albanin A had no effect on the synaptosomal membrane potential. The inhibition of N- and P/Q-type Ca2+ channels, calmodulin, adenylate cyclase (AC), and protein kinase A, abolished the effect of albanin A on the glutamate release evoked by 4-AP. Moreover, the albanin A-mediated inhibition of glutamate release was prevented by the Ca2+/calmodulin-stimulated AC1 inhibitor. Western blot showed that AC1, but not AC8, was presented in the synaptosomes, and albanin A reduced 4-AP-induced increases in synaptosomal cyclic adenosine monophosphate content. In addition, albanin A pretreatment substantially attenuated neuronal damage in a rat model of kainic acid-induced glutamate excitotoxicity. Our data reveal that albanin A suppresses glutamate release by decreasing Ca2+/calmodulin/AC1 activation in synaptosomes and exerts neuroprotective effect in vivo.

참고문헌 (Reference)

1 McMahon HT, "Transmitter glutamate release from isolated nerve terminals : evidence for biphasic release and triggering by localized Ca2+" 56 : 86-94, 1991

2 Wang L, "Three new compounds from Morus nigra L" 12 : 431-437, 2010

3 Yuan Q, "The mulberry(Morus alba L. )fruit-A review of characteristic components and health benefits" 65 : 10383-10394, 2017

4 Mohammad Iqbal Hossain Bhuiyan, "The Neuroprotective Potential of Cyanidin-3-glucoside Fraction Extracted from Mulberry Following Oxygen-glucose Deprivation" 대한약리학회 15 (15): 353-361, 2011

5 Zhu G, "Synaptic modification by L-theanine, a natural constituent in green tea, rescues the impairment of hippocampal long-term potentiation and memory in AD mice" 138 : 331-340, 2018

6 He X, "Structures, bioactivities and future prospective of polysaccharides from Morus alba(white mulberry) : A review" 245 : 899-910, 2018

7 Wong SB, "Rosiglitazone suppresses in vitro seizures in hippocampal slice by inhibiting presynaptic glutamate release in a model of temporal lobe epilepsy" 10 : e0144806-, 2015

8 Han GY, "Riluzole is a promising pharmacological inhibitor of bilirubininduced excitotoxicity in the ventral cochlear nucleus" 21 : 262-270, 2015

9 Chittajallu R, "Regulation of glutamate release by presynaptic kainate receptors in the hippocampus" 379 : 78-91, 1996

10 Chiu KM, "Protective effects of bupivacaine against kainic acid-induced seizure and neuronal cell death in the rat hippocampus" 38 : 522-530, 2015

11 Nicholls DG, "Presynaptic modulation of glutamate release" 116 : 15-22, 1998

12 Rodrı´guez-Moreno A, "Presynaptic kainate receptormediated facilitation of glutamate release involves Ca2+-calmodulin and PKA in cerebrocortical synaptosomes" 587 : 788-779, 2013

13 Wu LG, "Presynaptic inhibition of elicited neurotransmitter release" 20 : 204-212, 1997

14 Gomes NG, "Plants with neurobiological activity as potential targets for drug discovery" 33 : 1372-1389, 2009

15 Lim SH, "Pharmacological properties of Morus nigra L. (Black Mulberry)as a promising nutraceutical resource" 11 : E437-, 2019

16 Rehman MU, "Neuroprotective strategies for neurological disorders by natural products : An update" 17 : 247-267, 2019

17 Zhao LD, "Neuroprotective effect of Buyang Huanwu decoction against focal cerebral ischemia/reperfusion injury in rats—Time window and mechanism" 140 : 339-344, 2012

18 서경화, "Neuroprotective Effect of Prenylated Arylbenzofuran and Flavonoids from Morus alba Fruits on Glutamate-Induced Oxidative Injury in HT22 Hippocampal Cells" 한국식품영양과학회 18 (18): 403-408, 2015

19 Parvez MK, "Natural or plant products for the treatment of neurological disorders : Current knowledge" 19 : 424-428, 2018

20 Yi Chang, "Myricetin Inhibits the Release of Glutamate in Rat Cerebrocortical Nerve Terminals" 한국식품영양과학회 18 (18): 516-523, 2015

21 Kim HG, "Mulberry fruit protects dopaminergic neurons in toxin-induced Parkinson’s disease models" 104 : 8-16, 2010

22 Wang CP, "Mulberroside A protects against ischemic impairment in primary culture of rat cortical neurons after oxygen-glucose deprivation followed by reperfusion" 92 : 944-954, 2014

23 Cooper DM, "Molecular and cellular requirements for the regulation of adenylate cyclases by calcium" 31 : 912-915, 2003

24 Ferkany JW, "Kainic acid selectively stimulates the release of endogenous excitatory acid amino acid" 225 : 399-406, 1983

25 정재우, "Isoprenylated flavonoids from the root bark of Morus alba and their hepatoprotective and neuroprotective activities" 대한약학회 38 (38): 2066-2075, 2015

26 Sunahara RK, "Isoforms of mammalian adenylyl cyclase : Multiplicities of signaling" 2 : 168-184, 2002

27 Wen L, "Identification of two novel prenylated flavonoids in mulberry leaf and their bioactivities" 315 : 126236-, 2020

28 Choi DW, "Glutamate neurotoxicity and diseases of the nervous system" 1 : 623-634, 1988

29 Zhou Y, "Glutamate as a neurotransmitter in the healthy brain" 121 : 799-817, 2014

30 McEntee WJ, "Glutamate : Its role in learning, memory, and the aging brain" 111 : 391-401, 1993

31 Mdzinarishvili A, "Ginkgo extract EGb761 confers neuroprotection by reduction of glutamate release in ischemic brain" 15 : 94-102, 2012

32 Hashemi P, "Evaluation of the neuroprotective, anticonvulsant, and cognitionimprovement effects of apigenin in temporal lobe epilepsy : Involvement of the mitochondrial apoptotic pathway" 22 : 752-758, 2019

33 Kang TH, "Enhancement of neuroprotection of mulberry leaves(Morus alba L. )prepared by the anaerobic treatment against ischemic damage" 9 : 270-274, 2006

34 Chiu KM, "Dexmedetomidine protects neurons from kainic acid-induced excitotoxicity by activating BDNF signaling" 129 : 104493-, 2019

35 Lewerenz J, "Chronic glutamate toxicity in neurodegenerative diseases—What is the evidence?" 9 : 469-, 2015

36 Falco´n-Moya R, "Cerebellar kainate receptor-mediated facilitation of glutamate release requires Ca2+-calmodulin and PKA" 11 : 195-, 2018

37 Wang H, "Calmodulin-regulated adenylyl cyclases : Cross-talk and plasticity in the central nervous system" 63 : 463-468, 2003

38 Nicholls DG, "Calcium-dependent and-independent release of glutamate from synaptosomes monitored by continuous fluorometry" 49 : 50-57, 1987

39 Lin KC, "Bupropion attenuates kainic acidinduced seizures and neuronal cell death in rat hippocampus" 45 : 207-214, 2013

40 Bano D, "Beyond the critical point : An overview of excitotoxicity, calcium overload and the downstream consequences" 663 : 79-85, 2018

41 김세환, "Beneficial Effects of Silibinin Against Kainic Acidinduced Neurotoxicity in the Hippocampus in vivo" 한국뇌신경과학회 26 (26): 266-277, 2017

42 Chang Y, "Baicalein, a constituent of Scutellaria Baicalensis, reduces glutamate release and protects neuronal cell against kainic acid-induced excitotoxicity in rats" 44 : 943-962, 2016

43 Cheng Wei Lu, "Allicin Inhibits Glutamate Release from Rat Cerebral Cortex Nerve Terminals Through Suppressing Ca2+ Influx and Protein Kinase C Activity" 한국식품영양과학회 22 (22): 696-702, 2019

44 Grynkiewicz G, "A new generation of Ca2+indicators with greatly improved fluorescence properties" 260 : 3440-3450, 1985

45 Lu CW, "5-HT 1B receptor agonist CGS12066 presynaptically inhibits glutamate release in rat hippocampus" 86 : 122-130, 2018